First Eagle Investment Management LLC Has $555,000 Stock Position in International Flavors & Fragrances Inc. (NYSE:IFF)

First Eagle Investment Management LLC raised its position in shares of International Flavors & Fragrances Inc. (NYSE:IFF) by 14.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 6,569 shares of the specialty chemicals company’s stock after purchasing an additional 850 shares during the quarter. First Eagle Investment Management LLC’s holdings in International Flavors & Fragrances were worth $555,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Compagnie Lombard Odier SCmA raised its stake in International Flavors & Fragrances by 11.1% during the fourth quarter. Compagnie Lombard Odier SCmA now owns 114,179 shares of the specialty chemicals company’s stock worth $9,654,000 after buying an additional 11,406 shares during the last quarter. Choreo LLC grew its holdings in International Flavors & Fragrances by 55.7% during the 4th quarter. Choreo LLC now owns 24,401 shares of the specialty chemicals company’s stock worth $2,055,000 after acquiring an additional 8,728 shares during the period. Covea Finance raised its position in shares of International Flavors & Fragrances by 79.0% in the 4th quarter. Covea Finance now owns 123,090 shares of the specialty chemicals company’s stock worth $10,407,000 after acquiring an additional 54,340 shares in the last quarter. U.S. Capital Wealth Advisors LLC acquired a new position in shares of International Flavors & Fragrances in the 4th quarter valued at about $7,508,000. Finally, S.E.E.D. Planning Group LLC boosted its position in shares of International Flavors & Fragrances by 372.9% during the 4th quarter. S.E.E.D. Planning Group LLC now owns 63,104 shares of the specialty chemicals company’s stock valued at $5,335,000 after purchasing an additional 49,761 shares in the last quarter. Institutional investors and hedge funds own 96.02% of the company’s stock.

Insider Activity

In other International Flavors & Fragrances news, Director Kevin O’byrne bought 6,500 shares of the firm’s stock in a transaction dated Wednesday, March 5th. The stock was purchased at an average cost of $80.44 per share, with a total value of $522,860.00. Following the transaction, the director now directly owns 6,500 shares in the company, valued at $522,860. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.20% of the stock is currently owned by corporate insiders.

International Flavors & Fragrances Stock Up 0.7 %

Shares of NYSE:IFF opened at $79.76 on Monday. The business’s 50 day moving average is $83.41 and its 200 day moving average is $91.52. International Flavors & Fragrances Inc. has a 12-month low of $78.91 and a 12-month high of $106.77. The stock has a market cap of $20.39 billion, a price-to-earnings ratio of 84.85, a PEG ratio of 1.45 and a beta of 1.21. The company has a quick ratio of 1.93, a current ratio of 1.84 and a debt-to-equity ratio of 0.54.

International Flavors & Fragrances (NYSE:IFF) last posted its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.14. International Flavors & Fragrances had a net margin of 2.12% and a return on equity of 7.72%. The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.67 billion. On average, sell-side analysts forecast that International Flavors & Fragrances Inc. will post 4.32 earnings per share for the current fiscal year.

International Flavors & Fragrances Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 21st will be paid a $0.40 dividend. The ex-dividend date is Friday, March 21st. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.01%. International Flavors & Fragrances’s payout ratio is presently 170.21%.

Analyst Ratings Changes

Several equities analysts have issued reports on IFF shares. Stifel Nicolaus dropped their price target on International Flavors & Fragrances from $113.00 to $105.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Bank of America cut their target price on shares of International Flavors & Fragrances from $105.00 to $101.00 and set a “buy” rating on the stock in a research note on Thursday, February 20th. Cfra downgraded shares of International Flavors & Fragrances from a “buy” rating to a “sell” rating and set a $77.00 price target for the company. in a research note on Thursday, February 20th. JPMorgan Chase & Co. cut their price objective on shares of International Flavors & Fragrances from $107.00 to $104.00 and set an “overweight” rating on the stock in a research report on Thursday, February 20th. Finally, Wells Fargo & Company decreased their target price on International Flavors & Fragrances from $115.00 to $105.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, International Flavors & Fragrances presently has a consensus rating of “Moderate Buy” and a consensus price target of $103.50.

International Flavors & Fragrances Company Profile

International Flavors & Fragrances, Inc engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B’s Food & Beverage division and the food protection business of N&B’s Health & Biosciences division.